LOUELLA BAUMAN: Open Payments
NPI 1699166199 · PRESCOTT VALLEY, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 28 payments from 11 companies in 2025. Trend: 2023 $701 · 2024 $569 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $262 |
| GlaxoSmithKline, LLC. | 3 | $55 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Exact Sciences Corporation | 1 | $25 |
| Astellas Pharma US Inc | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: AIRSUPRA, BREZTRI, FARXIGA, TRELEGY ELLIPTA, CAPLYTA, Kerendia, The Cologuard Plus Collection Kit, REXULTI.
Industry payments across AZ — which companies pay providers there.
